Vanguard Group’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $22.8K | Buy |
|
|||||
|
2023
Q3 | $32.4K | Buy |
|
|||||
|
2023
Q2 | $35.4K | Hold |
|
|||||
|
2023
Q1 | $27.8K | Buy |
|
|||||
|
2022
Q4 | $39.8K | Hold |
|
|||||
|
2022
Q3 | $73K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $101K | Sell |
|
|||||
|
2021
Q4 | $263K | Buy |
|
|||||
|
2021
Q3 | $223K | Buy |
|
|||||
|
2021
Q2 | $224K | Buy |
|
|||||
|
2021
Q1 | $287K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $19K | Hold |
|
|||||
|
2019
Q3 | $44K | Hold |
|
|||||
|
2019
Q2 | $64K | Hold |
|
|||||
|
2019
Q1 | $133K | Hold |
|
|||||
|
2018
Q4 | $130K | Hold |
|
|||||
|
2018
Q3 | $174K | Buy |
|
|||||
|
2018
Q2 | $32K | Sell |
|
|||||
|
2018
Q1 | $463K | Buy |
|
|||||
|
2017
Q4 | $616K | Hold |
|
|||||
|
2017
Q3 | $1.2M | Sell |
|
|||||
|
2017
Q2 | $2.5M | Sell |
|
|||||
|
2017
Q1 | $4.55M | Hold |
|
|||||
|
2016
Q4 | $4.76M | Buy |
|
|||||
|
2016
Q3 | $7.46M | Buy |
|
|||||
|
2016
Q2 | $6.05M | Buy |
|
|||||
|
2016
Q1 | $6.85M | Buy |
|
|||||
|
2015
Q4 | $6.49M | Buy |
|
|||||
|
2015
Q3 | $7.57M | Buy |
|
|||||
|
2015
Q2 | $11.5M | Buy |
|